Hybrid spectrin type repeats produced by exon-skipping in dystrophin

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1764, Issue 6, 2006, Pages 993-999

  Menhart, Nick ^a  

^a Illinois Institute of Technology   (United States)

Author keywords

Domain; Dystrophin; Exon skipping; Hinge; Hybrid domain; Spectrin type repeat

Indexed keywords

DYSTROPHIN; RECOMBINANT PROTEIN; SPECTRIN;

ARTICLE; CELL VIABILITY; EXON; GENE DELETION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA PROCESSING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; DYSTROPHIN; EXONS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECOMBINANT PROTEINS; RNA SPLICING; SPECTRIN; TEMPERATURE; THERMODYNAMICS; VARIATION (GENETICS);

EID: 33745215797     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.03.017     Document Type: Article

References (44)

1. O'Brien K.F., and Kunkel L.M. Dystrophin and muscular dystrophy: past, present, and future. Mol. Genet. Metab. 74 (2001) 75-88
2. Sadoulet-Puccio H.M., and Kunkel L.M. Dystrophin and its isoforms. Brain Pathol. 6 (1996) 25-35
3. Sironi M., Cagliani R., Pozzoli U., Bardoni A., Comi G.P., Giorda R., and Bresolin N. The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett. 517 (2002) 163-166
4. Roberts R.G., Coffey A.J., Bobrow M., and Bentley D.R. Exon structure of the human dystrophin gene. Genomics 16 (1993) 536-538
5. Koenig M., and Kunkel L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265 (1990) 4560-4566
6. Marchler-Bauer A., Anderson J.B., Cherukuri P.F., DeWeese-Scott C., Geer L.Y., Gwadz M., He S., Hurwitz D.I., Jackson J.D., Ke Z., Lanczycki C.J., Liebert C.A., Liu C., Lu F., Marchler G.H., Mullokandov M., Shoemaker B.A., Simonyan V., Song J.S., Thiessen P.A., Yamashita R.A., Yin J.J., Zhang D., and Bryant S.H. CDD: a conserved domain database for protein classification. Nucleic Acids Res. 33 (2005) D192-D196
7. Menhart N., Mitchell T., Lusitani D., Topouzian N., and Fung L.W. Peptides with more than one 106-amino acid sequence motif are needed to mimic the structural stability of spectrin. J. Biol. Chem. 271 (1996) 30410-30416
8. Lusitani D., Menhart N., Keiderling T.A., and Fung L.W. Ionic strength effect on the thermal unfolding of alpha-spectrin peptides. Biochemistry 37 (1998) 16546-16554
9. MacDonald R.I., and Pozharski E.V. Free energies of urea and of thermal unfolding show that two tandem repeats of spectrin are thermodynamically more stable than a single repeat. Biochemistry 40 (2001) 3974-3984
10. Grum V.L., Li D., MacDonald R.I., and Mondragon A. Structures of two repeats of spectrin suggest models of flexibility. Cell 98 (1999) 523-535
11. Ylanne J., Scheffzek K., Young P., and Saraste M. Crystal structure of the alpha-actinin rod reveals an extensive torsional twist. Structure (Camb.) 9 (2001) 597-604
12. MacDonald R.I., and Cummings J.A. Stabilities of folding of clustered, two-repeat fragments of spectrin reveal a potential hinge in the human erythroid spectrin tetramer. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1502-1507
13. Flanigan K.M., von Niederhausern A., Dunn D.M., Alder J., Mendell J.R., and Weiss R.B. Rapid direct sequence analysis of the dystrophin gene. Am. J. Hum. Genet. 72 (2003) 931-939
14. Dent K.M., Dunn D.M., von Niederhausern A.C., Aoyagi A.T., Kerr L., Bromberg M.B., Hart K.J., Tuohy T., White S., den Dunnen J.T., Weiss R.B., and Flanigan K.M. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am. J. Med. Genet. A 134 (2005) 295-298
15. Decrouy A., Renaud J.M., Davis H.L., Lunde J.A., Dickson G., and Jasmin B.J. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability. Gene Ther. 4 (1997) 401-408
16. Friedrich O., Both M., Gillis J.M., Chamberlain J.S., and Fink R.H. Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice. J. Physiol. 555 (2004) 251-265
17. Moisset P.A., Gagnon Y., Karpati G., and Tremblay J.P. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts. Gene Ther. 5 (1998) 1340-1346
18. Harper S.Q., Hauser M.A., DelloRusso C., Duan D., Crawford R.W., Phelps S.F., Harper H.A., Robinson A.S., Engelhardt J.F., Brooks S.V., and Chamberlain J.S. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8 (2002) 253-261
19. Scott J.M., Li S., Harper S.Q., Welikson R., Bourque D., DelloRusso C., Hauschka S.D., and Chamberlain J.S. Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin. Neuromuscul. Disord. 12 Suppl. 1 (2002) S23-S29
20. Yue Y., Li Z., Harper S.Q., Davisson R.L., Chamberlain J.S., and Duan D. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108 (2003) 1626-1632
21. Ikezawa M., Cao B., Qu Z., Peng H., Xiao X., Pruchnic R., Kimura S., Miike T., and Huard J. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum. Gene Ther. 14 (2003) 1535-1546
22. Goyenvalle A., Vulin A., Fougerousse F., Leturcq F., Kaplan J.C., Garcia L., and Danos O. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306 (2004) 1796-1799
23. van Deutekom J.C. Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy. Eur. J. Hum. Genet. 13 (2005) 518-519
24. McClorey G., Fletcher S., and Wilton S. Splicing intervention for Duchenne muscular dystrophy. Curr. Opin. Pharmacol. 5 (2005) 529-534
25. Harper S.Q., Crawford R.W., DelloRusso C., and Chamberlain J.S. Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable. Hum. Mol. Genet. 11 (2002) 1807-1815
26. Sironi M., Pozzoli U., Cagliani R., Comi G.P., Bardoni A., and Bresolin N. Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum. Genet. 109 (2001) 73-84
27. Sironi M., Cagliani R., Comi G.P., Pozzoli U., Bardoni A., Giorda R., and Bresolin N. Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles. FEBS Lett. 537 (2003) 30-34
28. Winder S.J., Gibson T.J., and Kendrick-Jones J. Dystrophin and utrophin: the missing links!. FEBS Lett. 369 (1995) 27-33
29. Furnham N., Ruffle S., and Southan C. Splice variants: a homology modeling approach. Proteins 54 (2004) 596-608
30. Mehler M.F. Brain dystrophin, neurogenetics and mental retardation. Brain Res. Brain Res. Rev. 32 (2000) 277-307
31. Muntoni F., Torelli S., and Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2 (2003) 731-740
32. Koenig M., Monaco A.P., and Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53 (1988) 219-226
33. Ge L., and Rudolph P. Simultaneous introduction of multiple mutations using overlap extension PCR. Biotechniques 22 (1997) 28-30
34. C. Karreman, Fusion PCR, a one-step variant of the "megaprimer" method of mutagenesis Biotechniques 24 (1998) 736, 740, 742.
35. Wu Y., Huang H.W., and Olah G.A. Method of oriented circular dichroism. Biophys. J. 57 (1990) 797-806
36. Greenfield N., and Fasman G.D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8 (1969) 4108-4116
37. Cooper T.M., and Woody R.W. The effect of conformation on the CD of interacting helices: a theoretical study of tropomyosin. Biopolymers 30 (1990) 657-676
38. Kahana E., Marsh P.J., Henry A.J., Way M., and Gratzer W.B. Conformation and phasing of dystrophin structural repeats. J. Mol. Biol. 235 (1994) 1271-1277
39. MacDonald R.I., Musacchio A., Holmgren R.A., and Saraste M. Invariant tryptophan at a shielded site promotes folding of the conformational unit of spectrin. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 1299-1303
40. Eftink M.R. The use of fluorescence methods to monitor unfolding transitions in proteins. Biochemistry (Mosc.) 63 (1998) 276-284
41. Fontana A., de Laureto P.P., Spolaore B., Frare E., Picotti P., and Zambonin M. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 51 (2004) 299-321
42. Kaessmann H., Zollner S., Nekrutenko A., and Li W.H. Signatures of domain shuffling in the human genome. Genome Res. 12 (2002) 1642-1650
43. Lee C., and Wang Q. Bioinformatics analysis of alternative splicing. Brief Bioinform. 6 (2005) 23-33
44. Aartsma-Rus A., Janson A.A., Kaman W.E., Bremmer-Bout M., van Ommen G.J., den Dunnen J.T., and van Deutekom J.C. Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense. Am. J. Hum. Genet. 74 (2004) 83-92